Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07566533Not ApplicableCompleted

Comparison of Single-Layer and Triple-Layer TPU MaxFlex Aligners After Intraoral Use

Role: lead

NCT06733324Not ApplicableActive Not Recruiting

RCT of SCERTS (Social Communication, Emotional Regulation, Transactional Support) Program for Children With Autism Spectrum Disorder

Role: collaborator

NCT05405335Not ApplicableCompleted

Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome.

Role: lead

NCT04328272Phase 3Unknown

Effectiveness of Hydroxychloroquine in Covid-19 Patients

Role: collaborator

All 4 trials loaded